Abstract
The roles of protein conformational dynamics and allostery in function are well-known, yet the specific impact of interdomain dynamics remains less understood. This study utilizes matrix metalloprotease-1 (MMP1) as a model system to investigate the relationship between interdomain movement and enzymatic activity on fibrin, the primary component of blood clots. Using single-molecule Forster Resonance Energy Transfer (smFRET) and TIRF microscopy, we observed that the distance between the catalytic and hemopexin domains of MMP1 correlates directly with its activity level. By modulating activity through mutants, inhibitors, and enhancers, we demonstrate that these interdomain dynamics enable allosteric control of MMP1 function, providing a mechanical "switch" for clot degradation.
Introduction: The Mechanics of Fibrinolysis
Matrix metalloproteases (MMPs) are essential enzymes for remodeling the extracellular matrix, but their role in dissolving blood clots (fibrinolysis) is less understood than traditional pathways involving plasmin. MMP1 consists of a catalytic domain (the "scissors") and a hemopexin domain (the "anchor"), connected by a flexible linker. The central question of this research is whether the relative movement between these two domains is random noise or a functional mechanism that controls how effectively the enzyme can access and cleave the triple-helical structure of fibrin.
Experimental Methodology
The researchers employed an integrative approach combining single-molecule imaging with computational modeling. Single-molecule FRET was used to track the distance between the domains in real-time with sub-nanometer precision by attaching fluorescent dyes to specific residues (S142 and S366). Total Internal Reflection Fluorescence (TIRF) microscopy allowed for the imaging of single MMP1 molecules interacting with a thin layer of water-insoluble fibrin.
Activity was modulated using three primary conditions: an inactive mutant (E219Q), the inhibitor tetracycline, and the enhancer MMP9. Computational modeling, including Anisotropic Network Modeling (ANM) and molecular docking, was used to visualize how the enzyme physically fits onto the fibrin strands during these dynamic shifts.
Key Insights: The "Open" State and Allosteric Control
Experimental data and simulations revealed that the enzyme exists in two primary states: "closed" (~4.5 nm interdomain distance) and "open" (~5.4 nm). High catalytic activity correlates strongly with the "open" state. Computational modeling showed that when the two domains move apart, the catalytic pocket itself physically widens, allowing the bulky triple-helical fibrin chains to sit deeper in the enzyme's active site.
Interestingly, MMP1 behaves differently on fibrin than it does on collagen. While MMP9 (an enhancer) makes MMP1 "open" more on collagen, it actually increases the "closed" population on fibrin while still boosting overall activity. This suggests that the enzyme's mechanical communication is fine-tuned to the specific geometry of the substrate it is degrading.
Results and Kinetic Modeling
- Distance vs. Activity: Active MMP1 showed a higher prevalence of the "open" conformation compared to the catalytically inactive E219Q mutant.
- Inhibition: Tetracycline was found to bind between the two domains, physically "locking" them into a closed, inactive state.
- Kinetics: The dynamics were successfully modeled as a two-state Poisson process. The sum of the kinetic rates ($k_1 + k_2$) for interconversion between states was approximately 0.08 $s^{-1}$ on fibrin.
- Degradation Rates: Weight-based assays showed that while MMP1 degrades crosslinked fibrin at a rate of ~0.23 mg/h/µg, the addition of MMP9 causes this rate to jump to ~20 mg/h/µg, demonstrating significant enzymatic cooperativity.
Conclusion
This study demonstrates that the interdomain dynamics of MMP1 serve as a crucial allosteric regulator of its function on fibrin. By shifting between open and closed states, the enzyme can modulate its access to complex substrates. Future research may investigate how the mechanical properties of different tissues influence these dynamics, potentially opening the door for new classes of drugs that target the movement of enzymes rather than just their active sites.
Summary updated